Form 4 holding
President and CEO, Director
TFF Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 36,000
- Estimated value
- $14,098
- Report date
- 16 May 2022
- Price
- $0.3916
- Ownership
- Direct
Glenn R. Mattes
Insider Reports History
- Reporting-owner location
- Flemington, NJ
- Latest reporting-owner signature
-
/s/ Glenn R. Mattes, by Kirk Allen Coleman, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Glenn R. Mattes
Form 4 holding
President and CEO, Director
TFF Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 7,000
- Estimated value
- $2,741
- Report date
- 16 May 2022
- Price
- $0.3916
- Ownership
- Shares held by spouse
Insider Reports Filed by Glenn R. Mattes
4
TFF Pharmaceuticals, Inc.
- Report period
- 16 May 2022
- Transactions
- 1
- Transaction value
- +$76,480
- Accepted by SEC
- 17 May 2022, 21:51
- Role
- President and CEO, Director
- Next action
- Open filing details
4
TFF Pharmaceuticals, Inc.
- Report period
- 16 Sep 2021
- Transactions
- 1
- Transaction value
- +$71,000
- Accepted by SEC
- 16 Sep 2021, 13:35
- Role
- President and CEO, Director
- Next action
- Open filing details